The 1 analysts offering 12-month price forecasts for Neurobo Pharmaceuticals Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +33,942.55% increase from the last price of 1.41.
The current consensus among 1 polled investment analysts is to Buy stock in Neurobo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$4.50
Reporting Date Apr 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.